Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab. More
Articles
Why Is Huadi International (HUDI) Stock Up 90% Today?
There's some big news coming out of Huadi International today, sending HUDI stock roaring more than 90% higher this afternoon. More
Fed Rate Hike Alert: Is Federal Reserve Easing Ahead?
The Federal Reserve approved another 75-basis-point rate hike on Wednesday. Will this prove the end of the Fed's hawkish agenda? More
Should You Buy SOFI Stock After Q3 Earnings?
SoFi's Q3 earnings beat on both revenue and EPS, but SOFI stock has given up all of its earnings gains already. Should you buy in? More
OPEN Stock Alert: Opendoor Lays Off 18% of Staff
Although Opendoor reduced its headcount by 18%, OPEN stock faces long-term challenges stemming from a higher interest-rate environment. More
Muscle Through a Recession With Growth Stocks
We're in a bear market with a possible recession incoming. The best way to weather it is with growth stocks that will keep moving higher. More
I’m Not Worried About the Fed
The market is much bigger than any one person or any one policy announcement, however important it may be. But there is a better and smarter way to view “Fed days” and to invest… More
